Best Contraceptive Method for Trans Males (Excluding Implants and IUDs)
For trans males who decline implants and IUDs, depot medroxyprogesterone acetate (DMPA) injection is the most effective remaining option, providing both reliable contraception and menstrual suppression without requiring daily adherence. 1
Why DMPA is the Optimal Choice
DMPA offers several key advantages for trans males:
- Highly effective contraception with a typical-use failure rate of approximately 6% per year, significantly better than condoms (18%) or combined oral contraceptives (9%) 2
- Menstrual suppression occurs in most users, which can reduce gender dysphoria 3
- No daily adherence required – injections are given every 3 months, eliminating the risk of missed doses 2
- Progestin-only formulation avoids estrogen, which many trans males prefer to avoid due to gender-affirming considerations 3
- No genital examination required before initiation, reducing potential dysphoria triggers 2
Critical Counseling Point: Testosterone is NOT Contraception
You must explicitly counsel that testosterone does NOT provide reliable contraception, despite common misconceptions:
- 16.4% of trans males in one study believed testosterone was contraceptive, and 5.5% reported their providers incorrectly advised this 4
- Pregnancies have been documented in trans males taking testosterone, including 17% of reported pregnancies occurring after stopping testosterone and some while taking it irregularly 4
- Some trans males currently rely on testosterone for pregnancy prevention (3.6%), which is not evidence-based 5
Alternative Options if DMPA is Declined
If the patient declines DMPA, progestin-only pills (POPs) are the next best hormonal option:
- No examination required before initiation 2
- Backup contraception needed for 2 days if norethindrone/norgestrel formulation, or 7 days if drospirenone formulation, when started >5 days after menses 2
- Daily adherence required, which may be challenging for some patients 2
Combined hormonal contraceptives (CHCs) can be considered but require:
- Mandatory blood pressure measurement before initiation 1, 2
- Discussion about estrogen exposure, which some trans males may wish to avoid for gender-affirming reasons 3
- Counseling that sugammadex (if used perioperatively) decreases contraceptive efficacy for 1 week, and aprepitant for 1 month 1
Barrier Methods: Important but Insufficient Alone
External condoms are the most commonly used method among trans males (91.8% ever-use, 35.4% current use) but have significant limitations:
- High typical-use failure rate of 18% makes them inadequate as sole contraception for pregnancy prevention 2
- Should be recommended in addition to hormonal methods for STI protection 2
- Many trans males report not engaging in penis-in-vagina sex (5.7%) or sex with sperm-producing partners (4.8%), but this can change over time 5
Management of Breakthrough Bleeding on DMPA
If the patient experiences heavy or prolonged bleeding while using DMPA:
- NSAIDs for 5-7 days during bleeding episodes are first-line treatment 1, 6
- Provide reassurance that irregular bleeding is common initially and often improves over time 1
- Regular follow-up to assess satisfaction and address concerns 7
Common Pitfalls to Avoid
Do not assume contraceptive preferences based on gender identity:
- Trans males use a wide range of contraceptive methods, and clinicians should not assume estrogen avoidance is universal 5, 8
- Engage in patient-centered counseling using shared decision-making 9, 8
Do not delay contraception initiation:
- If uncertain about pregnancy status, the benefits of starting DMPA likely exceed any risk; start the method with follow-up pregnancy test in 2-4 weeks 1
Address fertility desires proactively: